Conversation with chief tech expert explores AI’s rise in the support space—and separating the substance from the noise.

This episode of Pharma Pulse covers Vinay Prasad’s return to lead the FDA’s biologics center after a brief resignation, new ...

Health systems across the United States are opening large-scale pharmacy service centers to streamline operations, improve inventory control, and ensure timely medication delivery amid drug shortages ...

In the final part of his Pharma Commerce video interview, Philip Sclafani, PwC's pharmaceutical and life sciences lead, ...

This episode of Pharma Pulse explores the FDA’s new proactive quality review initiative for drug manufacturing, GSK’s $370 ...

The CDMO’s new services at its Hopewell, NJ facility delivers scalable, phase-appropriate production, in-house quality ...

Patient access to treatment remains poor. For the second year in a row, patients with chronic conditions rated health plan ...

From rethinking launch price logic to implementing rebate-aware modeling and patient-first access programs, this installment ...

This episode of Pharma Pulse covers Bayer’s $2.3 billion cost-cutting overhaul, promising Phase III results for Eli Lilly’s ...

The GSK Flovent example highlights the consequences for patients and pharma of the decision to eliminate the Medicaid rebate cap.

In an era of increasing regulatory complexity, life sciences organizations are modernizing GxP compliance through digital ...

In the fifth part of her Pharma Commerce video interview, Heather Zenk, Cencora’s president of US supply chain, explores how ...